Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Feb
26
2012
Dealing with the Wild Side of Renewable Energy Development - Video Bracewell LLP
Feb
21
2012
CMS’s Proposed “Sunshine” Regulations: Implications for Research Faegre Drinker
Feb
19
2012
DOE Loan Guarantee Report Makes Recommendations Bracewell LLP
Feb
17
2012
FDA Publishes Draft Biosimilars Guidance McDermott Will & Emery
Feb
17
2012
FDA Issues Long-Awaited Draft Guidance Documents on Biosimilars Barnes & Thornburg LLP
Feb
16
2012
Military Wastewater Treatment System Generates Energy Varnum LLP
Feb
16
2012
ENERGY AND ENVIRONMENT UPDATE February 12, 2012 Mintz
Feb
15
2012
Has the Nuclear Renaissance Finally Begun? McDermott Will & Emery
Feb
14
2012
DOE Previews Significant Funding Opportunities for Offshore Wind McDermott Will & Emery
Feb
10
2012
FDA Issues Three Draft Guidances for Biosimilars Morgan, Lewis & Bockius LLP
Feb
6
2012
Maryland Poised to Develop Offshore Wind Resources McDermott Will & Emery
Jan
30
2012
Italian Government Stops Incentives for Ground-Mounted PV plants on Agricultural Lands McDermott Will & Emery
Jan
30
2012
Loophole in Senate Bill May Create Nuclear Risks Center for Public Integrity
Jan
29
2012
Texas Commission Requires Public Disclosure of Fracking Chemicals McDermott Will & Emery
Jan
22
2012
“Pascalization” Provides a New Alternative for Food Preservation Varnum LLP
Jan
18
2012
As Electric Vehicles Take Charge, Costs Power Down U.S. Department of Energy
Dec
31
2011
Energy Center Planned for Site TBD on Muskegon Lake Varnum LLP
Dec
26
2011
Broad Scope and Impact of California “Green Chemistry” Regulations McDermott Will & Emery
Dec
19
2011
Treasury Clarifies 5 Percent Safe Harbor Ownership Guidelines for Section 1603 Grants for Renewable Energy Projects McDermott Will & Emery
Dec
19
2011
Taking a Cue From Brazil's Sustainable Development Practices Past and Present Sheppard, Mullin, Richter & Hampton LLP
Dec
19
2011
Sino-U.S. Trade: Increasing Government Intervention Leads to Added Friction Greenberg Traurig, LLP
Dec
16
2011
Lake Michigan Winds Being Measured Varnum LLP
Dec
12
2011
FDA Announces Proposals for Biosimilars User Fees and Performance Review Goals Sheppard, Mullin, Richter & Hampton LLP
Nov
19
2011
Inexperience and Unproven Products: The Risks of Sustainable Construction Risk and Insurance Management Society, Inc. (RIMS)
Oct
31
2011
GOP to Subpoena White House over Solyndra Center for Public Integrity
Oct
27
2011
Is an Isolated DNA Patentable? Hunton Andrews Kurth
Oct
11
2011
Solar Energy Is Viable For Office Properties Sills Cummis & Gross P.C.
Oct
10
2011
Six Important Strategies To Reduce The Royalty Burden For A Pharmaceutical Product Sills Cummis & Gross P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins